Difference between revisions of "Main Page"
Jump to navigation
Jump to search
| Line 25: | Line 25: | ||
| − | + | NEW: '''[[How To's| "How To" help pages]]''' | |
| − | |||
| Line 34: | Line 33: | ||
*[[Media:EU.2009.08.04 Guideline on Clinical evaluation of diagnostic agents.pdf|EMEA Guideline on Clinical Evaluation of Diagnostic Agents (2009.08.04)]] | *[[Media:EU.2009.08.04 Guideline on Clinical evaluation of diagnostic agents.pdf|EMEA Guideline on Clinical Evaluation of Diagnostic Agents (2009.08.04)]] | ||
*[[Media:EU.2009.08.04 Appendix 1 to the guideline.pdf|EMEA Guideline - Appendix 1 (2009.08.04)]] | *[[Media:EU.2009.08.04 Appendix 1 to the guideline.pdf|EMEA Guideline - Appendix 1 (2009.08.04)]] | ||
| + | *[[Media:Oncology section.ppt|Oncology section from 2009 Imaging Biomarkers Roundtable]] | ||
| + | *[[Media:FREEMAN_FINAL_PROOF.pdf|2008 QIBA Kiosk at the RSNA Annual Meeting]] | ||
---- | ---- | ||
'''''<This Wiki is a Work In Progress: read [[Help:Contents|Help]], create an [[Wiki Accounts|account]], contribute>''''' | '''''<This Wiki is a Work In Progress: read [[Help:Contents|Help]], create an [[Wiki Accounts|account]], contribute>''''' | ||
Revision as of 00:54, 30 December 2009
This Wiki is for collaborative creation of QIBA materials and ongoing activities.
Quantitative Imaging Biomarkers Alliance (QIBA)
QIBA Mission: Improve the value and practicality of quantitative biomarkers by reducing variability across devices, patients and time.
QIBA is an initiative to advance quantitative imaging and the use of imaging biomarkers in clinical trials and clinical practice by engaging researchers, healthcare professionals and industry . This involves:
- collaborating to identify needs, barriers, and solutions to develop and test consistent, reliable, valid, and achievable quantitative imaging results across imaging platforms, clinical sites, and time.
- accelerating the development and adoption of hardware and software standards needed to achieve accurate and reproducible quantitative results from imaging methods.
QIBA develops Profile specifications and coordinates the necessary research and qualification groundwork.
QIBA currently has four active project groups:
NEW: "How To" help pages
Working Documents
- QIBA Roadmap (2009.09.21)
- EMEA Guideline on Clinical Evaluation of Diagnostic Agents (2009.08.04)
- EMEA Guideline - Appendix 1 (2009.08.04)
- Oncology section from 2009 Imaging Biomarkers Roundtable
- 2008 QIBA Kiosk at the RSNA Annual Meeting
<This Wiki is a Work In Progress: read Help, create an account, contribute>